tradingkey.logo
tradingkey.logo
Search

Heartbeam Inc

BEAT
Add to Watchlist
0.501USD
-0.017-3.21%
Close 07-31 16:00ETQuotes delayed by 15 min
20.59MMarket Cap
LossP/E TTM

Heartbeam Inc

0.501
-0.017-3.21%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-3.21%

5 Days

-2.17%

1 Month

-33.25%

6 Months

-65.48%

Year to Date

-79.14%

1 Year

-55.70%

Key Figures
0.519Open
0.519High
364.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.89%Turnover Ratio
0.517Prev. Close
0.493Low
133.58KTurnover
LossP/E Static
32.43P/B
0.00%Div Yield TTM
-310.39%ROA
4.00052wk High
1.33Volume Ratio
-19.45MNet Profit
41.13MShares
-0.5587EPS TTM
-0.86Beta
-495.61%ROE
0.54052wk Low
5.10%Amplitude
--Gross Margin
20.59MMarket Cap
-3.86Reward/Risk
7.30%Risk Rate

Heartbeam Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 4 analysts
Buy
Current Rating
3.375
Target Price
+564.24%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Heartbeam Inc
BEAT
4
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
29
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
0.001
Neutral
RSI(14)
34.657
Neutral
STOCH(KDJ)(9,3,3)
9.310
Oversold
ATR(14)
0.054
Low Volatility
CCI(14)
-97.357
Neutral
Williams %R
96.329
Oversold
TRIX(12,20)
-1.318
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.516
Sell
MA10
0.534
Sell
MA20
0.575
Sell
MA50
0.705
Sell
MA100
0.881
Sell
MA200
1.298
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Heartbeam Inc Info

HeartBeam, Inc. is a cardiac technology company. The Company focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. It is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. It is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Ticker SymbolBEAT
CompanyHeartbeam Inc
CEOEno (Robert P)
Websitehttps://www.heartbeam.com/

Shareholders

Shareholders
Shareholders
Proportion
Strome Mezzanine Fund, L.P.
5.87%
Schwartzberg (Andrew)
3.54%
Vanguard Capital Management, LLC
2.23%
Public Ventures LLC
1.99%
Vajdic (Branislav)
1.76%
Other
84.61%

FAQs

What is the current price of Heartbeam Inc (BEAT)?

The current price of Heartbeam Inc (BEAT) is 0.50.

What is the symbol of Heartbeam Inc?

The ticker symbol of Heartbeam Inc is BEAT.

What is the 52-week high of Heartbeam Inc?

The 52-week high of Heartbeam Inc is 4.00.

What is the 52-week low of Heartbeam Inc?

The 52-week low of Heartbeam Inc is 0.54.

What is the market capitalization of Heartbeam Inc?

The market capitalization of Heartbeam Inc is 20.69M.

Is Heartbeam Inc (BEAT) currently rated as Buy, Hold, or Sell?

According to analysts, Heartbeam Inc (BEAT) has an overall rating of Buy, with a price target of 3.38.

What is the Earnings Per Share (EPS TTM) of Heartbeam Inc (BEAT)?

The Earnings Per Share (EPS TTM) of Heartbeam Inc (BEAT) is -0.62.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.